Cart summary

You have no items in your shopping cart.

Prexasertib dihydrochloride

SKU: orb1226712

Description

A potent, selective, ATP-competitive inhibitor of CHK1 with Ki of 0.9 nM; potently abrogates the G2-M checkpoint activated by doxorubicin in p53-deficient HeLa cells with EC50 of 9 nM; causes replication catastrophe in vitro and in vivo; shows significant tumor growth inhibition in xenograft tumor models.Lung Cancer Phase 2 Clinical.

Images & Validation

Key Properties

CAS Number1234015-54-3
MW438.311
Purity>98% (HPLC)
FormulaC18H21Cl2N7O2
SMILESCOC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N.Cl.Cl
TargetChk
SolubilityDMSO: ≥ 32 mg/mL

Bioactivity

In Vivo
Animal model: Female CD-1 nu-/nu-mice (26-28 g) with Calu-6 cells. Dosage: 1, 3.3, or 10 mg/kg. Administration: SC; twice daily for 3 days, rest 4 days; for three cycles. Result: Caused statistically significant tumor growth inhibition (up to 72.3%). Animal model: Female CD-1 nu-/nu-mice (26-28 g) with Calu-6 cells. Dosage: 15 mg/kg (Pharmacokinetic Analysis). Administration: SC (200 μL). Result: CHK1 was 7 ng/mL at 12 hours and 3 ng/mL by 24 hours in plasma exposures. Phosphorylation of both H2AX (S139) and RPA2 (S4/S8) was detectable at 4 hours, showing the rapid occurrence of DNA damage.
In Vitro
Cell Cycle Analysis Cell line: HeLa cells. Concentration: 33, 100 nM. Incubation time: For 7 hours. Result: Had an IC50 of 37 nM and resulted in the G2-M population received DNA damage during S-phase but continued to progress through the cell cycle into an early mitosis. Western blot analysis. Cell line: HT-29 cells. Concentration: 8, 16, 31, 63, 125, 250 nM. Incubation time: Pre-treated for 15 minutes. Result: Inhibited CHK1 autophosphorylation (S296) and CHK2 autophosphorylation (S516) (IC50 of less than 31 nM) in HT-29 cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LY-2606368 dihydrochloride | LY 2606368 dihydrochloride

Similar Products

  • Prexasertib dihydrochloride [orb1302948]

    99.82% (May vary between batches)

    1234015-54-3

    438.31

    C18H21Cl2N7O2

    1 mg, 2 mg, 5 mg, 100 mg, 25 mg, 500 mg, 1 ml x 10 mM (in DMSO), 10 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Prexasertib dihydrochloride (orb1226712)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 100.00
5 mg
$ 150.00
10 mg
$ 220.00
25 mg
$ 400.00
50 mg
$ 610.00
100 mg
$ 880.00
500 mg
$ 1,800.00